Nasdaq Stockholm

Immunovia AB (publ)

ISIN SE0006091997Filings at the FI

At a glance

Most recent filing on January 6, 2024 — a sale by michael Lofman on Jan 3, 2024.

We hold 28 visible filings, going back to September 17, 2018.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 28 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 28. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

michael Lofman Board member
1,292,570 SEKOpen-market sale
TradedJan 3, 2024FiledJan 6, 2024
Jeffrey Borcherding Chief executive officer
$61,810Open-market buy
TradedJun 7, 2023FiledJun 8, 2023
Myrtila AB Closely associated: Board member
99,991 SEKOpen-market buy
TradedApr 6, 2023FiledApr 28, 2023
Peter Andersen Board member
186,000 SEKOpen-market buy
TradedFeb 22, 2022FiledFeb 23, 2022
Martin Moeller Board member
141,293 SEKOpen-market buy
TradedSep 2, 2021FiledSep 3, 2021